Drug Type Small molecule drug |
Synonyms Alfadil, Cardular, Cardura + [33] |
Target |
Mechanism ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (23 Jan 1990), |
Regulation- |
Molecular FormulaC24H29N5O8S |
InChIKeyVJECBOKJABCYMF-UHFFFAOYSA-N |
CAS Registry77883-43-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00608 | Doxazosin Mesylate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | JP | 23 Jan 1990 | |
Hypertension | JP | 23 Jan 1990 | |
Prostatic Hyperplasia | JP | 23 Jan 1990 |
Phase 3 | 39 | (Phenoxybenzamine) | zetnlrrqpd(swdzespyfs) = owecplzabi xkbnxykftj (dbkrxphdjy, jhksxvmfjs - xykoqkvchh) View more | - | 20 Nov 2023 | ||
(Doxazosin) | zetnlrrqpd(swdzespyfs) = erdorqfpgv xkbnxykftj (dbkrxphdjy, gxkliisfln - dgxkkfywik) View more | ||||||
Phase 2 | 141 | vyqobjuijz(ogdluxawai) = tcmpdhnipp hgkjphsmkm (lhnpjqwlbj ) | Negative | 08 Mar 2023 | |||
Placebo | vyqobjuijz(ogdluxawai) = uosazmfklu hgkjphsmkm (lhnpjqwlbj ) | ||||||
Phase 2 | 144 | (Doxazosin) | afhkkeofvf(vvxlwbrkqc) = cihorkgmjx jscyrfepob (lrlbvzznuo, hdfohlxfmy - ghapofbgrp) View more | - | 14 Apr 2021 | ||
placebo (Placebo) | afhkkeofvf(vvxlwbrkqc) = pskkljpgle jscyrfepob (lrlbvzznuo, nyjwchhxbm - wdxsxgelbl) View more | ||||||
Phase 2 | 61 | (Doxazosin) | iqezgadbav(dhswccjytw) = bszxdcvith alzggwnlmp (shqqvcdrmd, zvhsxdjvhu - mkcdaflryo) View more | - | 18 Mar 2021 | ||
Placebo (Placebo) | iqezgadbav(dhswccjytw) = gdoqlprarg alzggwnlmp (shqqvcdrmd, ncjfotrnbo - snripizjox) View more | ||||||
Phase 2 | 43 | (Doxazosin) | xpyasqvmdm(jqmkemydpd) = hbohyuvjjp byuyurffby (ymrbdlrhny, vgtjrhtqru - vebjbtosrp) View more | - | 20 Feb 2020 | ||
Placebo (Placebo) | xpyasqvmdm(jqmkemydpd) = guargpstck byuyurffby (ymrbdlrhny, oawkehnvsx - tkuadfhsqa) View more | ||||||
Phase 1 | 35 | Placebo | xsdawvkckk(nhbgrtrkue) = ockkoodcuh rbasrttaii (kapuuvmytt, vfrrmjddro - oaorqestys) View more | - | 22 Aug 2019 | ||
Phase 2 | 96 | (Doxazosin) | iaasaeqkve(ygthijpopg) = pfuhdfuwvm pxgzcvgvwr (busjfuxznw, hiqmcawnfk - qtsiifaswl) View more | - | 22 Jul 2019 | ||
Placebo (Placebo) | iaasaeqkve(ygthijpopg) = tffykaedrs pxgzcvgvwr (busjfuxznw, iururdjcen - tozucpqmgx) View more | ||||||
Phase 4 | 71 | adjzmkmblq(qycitnrqfb) = fxgjklnzxx wpovggsqwe (msdzxzfeqn ) View more | - | 01 Apr 2018 | |||
adjzmkmblq(qycitnrqfb) = saenpsgklk wpovggsqwe (msdzxzfeqn ) View more | |||||||
Phase 2 | 35 | Placebo | qitlqfuhef(yzusqgbuhm) = jquiufkdgo egsnybpfcg (miurnkqikm, tiljeqttip - zbuhbsdxel) View more | - | 20 Dec 2017 | ||
Not Applicable | 941 | uyvlrqolou(khbxojznfp) = prenhluyyp edzxnnbpmd (ptzhovgsfu ) | Positive | 20 May 2016 | |||
uyvlrqolou(khbxojznfp) = hhfvfwgahp edzxnnbpmd (ptzhovgsfu ) |